Decision Back
This week, Lanny sat down with Arvind Balasundaram, a pharma analytics leader with more than 30 years of experience across Regeneron, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer. Together, they explore how pharma analytics has evolved—and how agentic AI will push data and analytics teams up the value chain from delivering insights to driving better decisions. The conversation covers the future of AI in pharma, the changing role of analytics teams, and why the biggest opportunity lies not just in generating more insight, but in improving the quality and speed of decision-making.
9 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Decision Back-Community!